234 related articles for article (PubMed ID: 10645495)
21. North Central Cancer Treatment Group (NCCTG).
Loprinzi CL
J Natl Cancer Inst Monogr; 1996; (20):79-80. PubMed ID: 8750472
[No Abstract] [Full Text] [Related]
22. Low-dose megestrol acetate for appetite stimulation in advanced cancer.
Donnelly S; Walsh TD
J Pain Symptom Manage; 1995 Apr; 10(3):182-3. PubMed ID: 7629410
[No Abstract] [Full Text] [Related]
23. A new horizon of herbal medicines in anorexia-cachexia syndrome.
Inui A
Curr Pharm Des; 2012; 18(31):4747-8. PubMed ID: 22950447
[No Abstract] [Full Text] [Related]
24. Anorexia and cachexia.
Enck RE
Am J Hosp Care; 1987; 4(5):13-5. PubMed ID: 3476126
[No Abstract] [Full Text] [Related]
25. Cytokines and cancer anorexia cachexia syndrome.
Bennani-Baiti N; Davis MP
Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated anorexia and cachexia. Implications for drug therapy.
Loprinzi CL; Goldberg RM; Burnham NL
Drugs; 1992 Apr; 43(4):499-506. PubMed ID: 1377116
[TBL] [Abstract][Full Text] [Related]
27. Update on anorexia and cachexia.
Strasser F; Bruera ED
Hematol Oncol Clin North Am; 2002 Jun; 16(3):589-617. PubMed ID: 12170570
[TBL] [Abstract][Full Text] [Related]
28. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
Graf SA; Garcia JM
Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
[TBL] [Abstract][Full Text] [Related]
29. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
Currow DC; Skipworth RJ
Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
[TBL] [Abstract][Full Text] [Related]
30. Treatment of anorexia with megestrol acetate.
Tchekmedyian NS
Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
[TBL] [Abstract][Full Text] [Related]
31. Anamorelin for cancer cachexia.
Nishie K; Sato S; Hanaoka M
Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
[TBL] [Abstract][Full Text] [Related]
32. Palliative care.
Davis CL; Hardy JR
BMJ; 1994 May; 308(6940):1359-62. PubMed ID: 7517247
[TBL] [Abstract][Full Text] [Related]
33. IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment.
Chowdhury IH; Rahman S; Afroze YJ; Shovah ST
Pharmacol Res; 2024 May; 203():107129. PubMed ID: 38461961
[TBL] [Abstract][Full Text] [Related]
34. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
[TBL] [Abstract][Full Text] [Related]
35. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG
J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749
[TBL] [Abstract][Full Text] [Related]
36. Role of corticosteroids in palliative care.
Shih A; Jackson KC
J Pain Palliat Care Pharmacother; 2007; 21(4):69-76. PubMed ID: 18032321
[TBL] [Abstract][Full Text] [Related]
37. Contemporary drug therapy in palliative care: new directions.
D'Olimpio J
Cancer Invest; 2001; 19(4):413-23. PubMed ID: 11405180
[No Abstract] [Full Text] [Related]
38. Understanding cachexia and excessive weight loss in cancer.
Hemming L; Maher D
Br J Community Nurs; 2005 Nov; 10(11):492-5. PubMed ID: 16301922
[TBL] [Abstract][Full Text] [Related]
39. Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
Cabeza C; Corsi O; Pérez-Cruz P
Medwave; 2017 Dec; 17(9):e7130. PubMed ID: 29286357
[TBL] [Abstract][Full Text] [Related]
40. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
